farnesol has been researched along with Viremia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Galkina, SA; Joshi, P; Kosikova, G; Moreno, ME; Murphey-Corb, M; Parniak, MA; Reeve, AB; Rivera, JM; Sarafianos, SG; Sloan, B; Stoddart, CA | 1 |
1 other study(ies) available for farnesol and Viremia
Article | Year |
---|---|
Oral administration of the nucleoside EFdA (4'-ethynyl-2-fluoro-2'-deoxyadenosine) provides rapid suppression of HIV viremia in humanized mice and favorable pharmacokinetic properties in mice and the rhesus macaque.
Topics: Animals; Anti-HIV Agents; Blood-Brain Barrier; Diazonium Compounds; Farnesol; Flow Cytometry; Half-Life; HIV Infections; HIV-1; Humans; In Vitro Techniques; Macaca mulatta; Mice; Mice, SCID; Monocytes; Reverse Transcriptase Inhibitors; RNA, Viral; Simian Immunodeficiency Virus; Viremia | 2015 |